Hermetica Superfood Encyclopedia
The Short Answer
Trametes ochracea produces triterpenoids, phenolic acids, and beta-glucans that exert antioxidant activity primarily through free radical scavenging of reactive oxygen species, with structural homology to the bioactive compounds characterized in the closely related Trametes versicolor. In vitro studies on Trametes genus extracts demonstrate DPPH radical scavenging activity reaching 62.9% at 0.5 mg/mL concentration and total phenolic content comparable to T. versicolor at approximately 12–49 mg/g dry weight, though species-specific clinical data for T. ochracea remain absent from peer-reviewed literature.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordTrametes ochracea benefits
Ochre Bracket Fungus — botanical close-up
Health Benefits
**Antioxidant Activity**
Trametes ochracea shares genus-level triterpenoid and phenolic chemistry with T. versicolor, where methanolic extracts demonstrate DPPH inhibition of 32.62–72.32% and nitrite/hydrogen peroxide scavenging of 34.31–62.30%, effects attributable to gallic acid, protocatechuic acid, and related polyphenols that donate hydrogen atoms to neutralize free radicals.
**Immune Modulation Potential**
Beta-glucans, which comprise up to 42% of Trametes biomass in submerged cultivation, interact with pattern recognition receptors such as Dectin-1 on innate immune cells, potentially stimulating macrophage activation and natural killer cell function, though this mechanism has not been confirmed in T. ochracea-specific trials.
**Anti-inflammatory Properties**
Phenolic constituents including p-hydroxybenzoic acid (113.16 µg/g dry weight in T. versicolor) and homogentisic acid are associated with inhibition of pro-inflammatory mediators in Trametes genus extracts, suggesting potential modulation of cyclooxygenase and lipoxygenase pathways at concentrations achievable in ethanolic extracts.
**Antimicrobial Activity**
In vitro assays on Trametes species extracts document activity against both gram-positive and gram-negative bacterial strains, with saponin content (approximately 70.6 µg/mL) and flavonoid fractions (9.50 µg/mL) implicated in membrane disruption and inhibition of microbial enzymatic processes.
**Hepatoprotective Potential**
Triterpenoids characteristic of the Trametes genus, analogous to the ganoderic acid class found in related polyporales, may support hepatic antioxidant defenses by upregulating endogenous enzymes such as superoxide dismutase and catalase, though this has not been studied directly in T. ochracea.
**Nutritional Amino Acid Contribution**
Trametes versicolor fruiting bodies contain measurable concentrations of essential amino acids including leucine (72.41 mg/100 g dry weight) and isoleucine (60.07 mg/100 g dry weight), suggesting T. ochracea fruiting bodies may similarly contribute to dietary protein intake, though species-specific amino acid profiling has not been published.
**Carotenoid and Vitamin-like Antioxidants**: Beta-carotene (8
34 mg/g) and lycopene (6.85 mg/g) identified in T. versicolor suggest that related Trametes species may provide lipid-soluble antioxidants that protect cellular membranes from lipid peroxidation, with ascorbic acid equivalents (11.03 mg/g) further supporting water-soluble radical quenching activity.
Origin & History
Natural habitat
Trametes ochracea is a wood-decaying polypore fungus distributed across temperate and subtropical forests in Europe, Asia, North America, and parts of Africa, where it grows saprotrophically on dead or dying hardwood logs and stumps. It thrives in moist, shaded woodland environments and is commonly found on oak, beech, and other broadleaf deciduous trees, fruiting predominantly in autumn and winter. Like other members of the Trametes genus within the family Polyporaceae, it forms leathery, bracket-shaped fruiting bodies and has been documented in wild-harvested ethnobotanical traditions, though formal cultivation protocols remain largely undeveloped compared to its close relative Trametes versicolor.
“Trametes ochracea has not been prominently documented in classical pharmacopeias or ethnobotanical treatises as a standalone medicinal species, and its historical use is largely conflated with broader Trametes genus applications in regions where multiple bracket fungi were employed interchangeably in folk medicine. The Trametes genus as a whole has roots in East Asian traditional medicine, particularly within Chinese and Japanese herbalism, where Trametes versicolor — known as Yun Zhi in Chinese and Kawaratake in Japanese — was used for centuries as a tonic to support vital energy, digestion, and resistance to illness, with preparations typically made as hot water decoctions. In European folk traditions, wood-rotting polypore fungi including Trametes species were occasionally employed as styptics or wound coverings owing to their fibrous texture, though specific medicinal attribution to T. ochracea is absent from documented historical sources. Modern pharmacognostic interest in T. ochracea has emerged primarily from ecological surveys and phytochemical screening programs seeking to identify bioactive potential across underexplored Polyporaceae species, rather than from revival of documented traditional practice.”Traditional Medicine
Scientific Research
No peer-reviewed clinical trials, randomized controlled studies, or human pharmacokinetic studies have been published specifically examining Trametes ochracea as a medicinal or nutritional ingredient, representing a critical gap in the evidence base for this species. Available scientific literature consists exclusively of in vitro phytochemical characterization and bioassay studies conducted on Trametes versicolor and unspecified Trametes species, with antioxidant endpoints (DPPH IC50, FRAP values) and antimicrobial minimum inhibitory concentrations reported at the p < 0.05 significance threshold against pharmaceutical standards such as BHA. HPLC-based quantification studies on T. versicolor have identified and measured 28 discrete compounds including 11 phenolic acids, 6 flavonols, and 6 flavones, providing a phytochemical framework that may partially apply to T. ochracea given shared genus membership, but direct compositional equivalence has not been established. The overall evidence quality for T. ochracea specifically is rated as very low (preclinical, in vitro only), and extrapolation from T. versicolor data — which itself lacks large-scale RCT support — must be made with significant caution.
Preparation & Dosage
Traditional preparation
**Whole Dried Fruiting Body Powder**
1–3 g daily as crude powder, taken with food to aid tolerability
No established dose for T. ochracea; T. versicolor reference doses in traditional use contexts range from .
**Methanolic or Ethanolic Extract**
Research extracts prepared via solvent extraction with subsequent evaporation; standardization percentages for T. ochracea have not been published; T. versicolor extracts are sometimes standardized to 15–40% beta-glucan content.
**Hot Water Decoction (Traditional)**
Bracket fungi in the Trametes genus have been prepared as long-simmered decoctions (30–60 minutes) in folk medicine traditions; no specific ratios or volumes established for T. ochracea.
**Submerged Fermentation Biomass**
713 mg/mL); not currently available as a commercial supplement form for this species
Laboratory biomass production via submerged cultivation yields high beta-glucan concentrations (up to 1..
**Standardized Polysaccharide Extract**
No commercially standardized T. ochracea extract exists; beta-glucan-standardized Trametes genus products are used as reference models only.
**Timing**
No clinical timing data available; general polysaccharide supplement guidance suggests administration with or between meals to optimize gastrointestinal tolerability.
Nutritional Profile
Trametes ochracea has not been subjected to direct proximate analysis; nutritional data are extrapolated from the closely related T. versicolor, in which dry fruiting bodies contain measurable protein-forming amino acids including leucine (72.41 mg/100 g dry weight) and isoleucine (60.07 mg/100 g dry weight), alongside a broader essential amino acid complement consistent with other edible polypores. Phenolic phytochemicals represent the most pharmacologically characterized fraction, with T. versicolor reference values including total phenolics at 48.71 mg/g, gallic acid at 45.72 mg/g, rutin at 12.50 mg/g, and ascorbic acid equivalents at 11.03 mg/g dry weight; individual phenolic acids include p-hydroxybenzoic acid (113.16 µg/g), protocatechuic acid (10.07 µg/g), vanillic acid (5.21 µg/g), and homogentisic acid (1.24 µg/g). Lipid-soluble antioxidants beta-carotene (8.34 mg/g) and lycopene (6.85 mg/g) contribute to the carotenoid profile, while beta-glucan polysaccharides — reaching up to 42% of dry biomass in submerged culture — constitute the dominant structural carbohydrate fraction with immunomodulatory relevance. Bioavailability of polyphenols from bracket fungi is expected to be moderate and influenced by food matrix effects, solvent polarity of extraction, and gut microbiome-mediated biotransformation of phenolic precursors into absorbable metabolites.
How It Works
Mechanism of Action
The primary antioxidant mechanism in Trametes ochracea, inferred from genus-level data, involves direct hydrogen atom transfer and single-electron donation from phenolic hydroxyl groups — particularly those of gallic acid, protocatechuic acid, and rutin — to neutralize DPPH, hydroxyl, and nitric oxide radicals, a process confirmed by FTIR identification of broad –OH stretching at 3272 cm⁻¹ and conjugated C=C bonds at 1640 cm⁻¹ in carotenoid and polyphenol fractions. Beta-glucans present in Trametes biomass act as biological response modifiers by binding to Dectin-1 and complement receptor 3 (CR3) on macrophages and dendritic cells, triggering downstream NF-κB and MAPK signaling cascades that upregulate cytokine production and phagocytic activity. Triterpenoids characteristic of the Polyporaceae family are hypothesized to inhibit HMG-CoA reductase and modulate sterol biosynthetic pathways, while also suppressing pro-inflammatory COX-2 enzyme expression, though these specific targets have not been experimentally confirmed for T. ochracea isolates. Saponin and anthraquinone fractions identified in Trametes sp. extracts may additionally disrupt microbial cell membrane integrity through amphipathic intercalation, contributing to the observed in vitro antimicrobial activity across bacterial and fungal challenge models.
Clinical Evidence
No clinical trials have investigated Trametes ochracea in human subjects, and the species is absent from registered clinical trial databases as of current literature review. The closest available human-adjacent data derives from research on Trametes versicolor, where polysaccharide-K (PSK) and polysaccharide-peptide (PSP) extracts have been evaluated in oncology contexts in Asian clinical settings, but these findings cannot be responsibly attributed to T. ochracea without species-specific corroboration. In vitro antioxidant and antimicrobial studies on Trametes genus extracts report statistically significant effects (p < 0.05) comparable to positive controls such as BHA and standard antibiotics, but the translation of these endpoints to clinically meaningful human outcomes has not been demonstrated. Confidence in any therapeutic application of T. ochracea must be classified as very low pending dedicated preclinical mechanistic studies, toxicology data, and eventual phase I human safety trials.
Safety & Interactions
No formal toxicological studies, human safety trials, maximum tolerated dose studies, or pharmacovigilance reports have been published specifically for Trametes ochracea, leaving its safety profile essentially uncharacterized in the peer-reviewed literature. In vitro bioactivity data from Trametes genus extracts do not demonstrate direct cytotoxicity at the concentrations studied, and the broader food-grade use of related polypore fungi in Asian cuisines provides indirect, low-level reassurance, but this cannot substitute for species-specific safety assessment. Potential drug interactions are unstudied for T. ochracea; by analogy with T. versicolor and its polysaccharide fractions, caution may be warranted with immunosuppressive medications (e.g., tacrolimus, cyclosporine) given theoretical beta-glucan-mediated immune stimulation, and with anticoagulants given phenolic content that may influence platelet aggregation pathways. Use during pregnancy, lactation, and in pediatric populations cannot be recommended given the complete absence of safety data, and individuals with known fungal allergies or autoimmune conditions should consult a qualified healthcare provider before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Coriolus ochraceusPolyporus ochraceus Berk.Ochre Bracket FungusTrametes ochracea (Trametes ochracea)Ochre TrametesTrametes ochracea (Berk.) Ryvarden
Frequently Asked Questions
What is Trametes ochracea and how does it differ from Turkey Tail mushroom?
Trametes ochracea is a wood-decaying bracket fungus in the same Trametes genus as Turkey Tail (Trametes versicolor), sharing a similar leathery, shelf-shaped fruiting body and overlapping phytochemical profiles including phenolic acids, beta-glucans, and triterpenoids. The key practical difference is that T. versicolor has been extensively studied for its PSK and PSP polysaccharide extracts with documented immunological activity, while T. ochracea remains scientifically undercharacterized with no species-specific clinical or pharmacological trials published to date. Both are saprotrophic hardwood decomposers, but T. ochracea tends toward a more ochre-yellow coloration of the bracket surface compared to the multicolored zonate bands typical of Turkey Tail.
Does Trametes ochracea have antioxidant properties?
Yes, Trametes ochracea is categorized primarily for its triterpenoid and phenolic content, which confer antioxidant activity through free radical scavenging mechanisms analogous to those documented in closely related Trametes species. Genus-level in vitro data show DPPH radical inhibition of 62.9% at 0.5 mg/mL and total phenolic content in the range of 12–49 mg/g dry weight, with gallic acid, protocatechuic acid, and rutin identified as major contributing compounds. However, these figures derive from T. versicolor and unspecified Trametes species research; no DPPH, FRAP, or ORAC assay data have been published specifically using T. ochracea extracts.
Is there any clinical evidence supporting Trametes ochracea as a supplement?
No clinical trials, human pharmacokinetic studies, or randomized controlled studies have been conducted on Trametes ochracea as of current literature review, making it one of the least clinically characterized species within the medicinally relevant Trametes genus. All available data are restricted to in vitro phytochemical characterization and bioassay endpoints (antioxidant, antimicrobial) conducted on genus-level or T. versicolor extracts, which cannot be directly attributed to T. ochracea without species-specific investigation. Individuals seeking evidence-based supplementation should be aware that the evidence score for T. ochracea is very low (preclinical only) and that therapeutic claims cannot be substantiated by current science.
What is the recommended dose of Trametes ochracea?
No evidence-based dosage guidelines exist for Trametes ochracea, as the species has not been evaluated in human clinical trials or formal pharmacological dose-finding studies. By general reference to Trametes versicolor supplementation conventions used in research settings, crude dried powder doses of 1–3 g daily and standardized polysaccharide extracts at doses providing approximately 100–300 mg beta-glucans have been explored, but these figures should not be assumed applicable to T. ochracea without further validation. Anyone considering use of T. ochracea as a supplement should consult a qualified healthcare provider, as standardized commercial preparations and safety-verified dosing regimens are not yet established for this species.
Is Trametes ochracea safe to use, and are there any known side effects?
The safety profile of Trametes ochracea is currently unknown due to the complete absence of published toxicology studies, human safety trials, or adverse event reporting for this specific species. No side effects, contraindications, or drug interaction data have been documented, though theoretical caution is advised for individuals using immunosuppressive drugs or anticoagulants, by analogy with the immune-stimulating beta-glucan and platelet-active phenolic fractions characterized in related Trametes species. Pregnancy, lactation, and pediatric use cannot be considered safe in the absence of relevant data, and persons with fungal allergies or autoimmune conditions should avoid use without medical supervision.
How does Trametes ochracea compare to other medicinal mushrooms in terms of polyphenol content?
Trametes ochracea contains similar bioactive polyphenols to its close relative Turkey Tail, including gallic acid and protocatechuic acid, which are responsible for antioxidant activity. While both species belong to the Trametes genus and share comparable chemical profiles, T. ochracea's specific polyphenol concentration may vary depending on growing conditions and substrate, making direct equivalency difficult without standardized extraction data. Research suggests that genus-level chemistry provides consistent antioxidant potential across Trametes species, though individual potency can differ from unrelated medicinal mushrooms like Cordyceps or Reishi.
What extraction method is best for maximizing Trametes ochracea's antioxidant compounds?
Methanolic extraction has demonstrated superior antioxidant yield from Trametes species, achieving DPPH inhibition rates of 32.62–72.32%, as the polar solvent effectively dissolves phenolic compounds and triterpenoids. Hot water extraction is also commonly used in traditional applications and supplements, though it may capture different compounds than alcohol-based methods. For optimal bioavailability of polyphenols like gallic acid and protocatechuic acid, dual-extraction (water followed by alcohol) or standardized extracts are often preferred in supplement formulations.
Can Trametes ochracea be used preventatively for oxidative stress-related conditions?
Trametes ochracea's demonstrated hydrogen peroxide and nitrite scavenging abilities (34.31–62.30% inhibition) suggest potential utility as a preventative antioxidant supplement, though human clinical trials specifically examining disease prevention are limited. The polyphenol content indicates it could support general antioxidant defense mechanisms that contribute to cellular health over time. However, supplementation should not replace established medical prevention strategies, and individuals with specific health conditions should consult healthcare providers before using it prophylactically.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w trametes-ochracea-trametes-ochracea-berk-ryvarden curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
